Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIIIW) Gains from Investment Securities (2019 - 2025)

P3 Health Partners' Gains from Investment Securities history spans 7 years, with the latest figure at -$12.3 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 12252.48% year-over-year to -$12.3 million; the TTM value through Dec 2025 reached $2.6 million, up 117.96%, while the annual FY2024 figure was $103000.0, 543.75% up from the prior year.
  • Gains from Investment Securities reached -$12.3 million in Q4 2025 per PIIIW's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $14.3 million in Q1 2025 to a low of -$12.3 million in Q4 2025.
  • Average Gains from Investment Securities over 5 years is -$985593.2, with a median of -$311000.0 recorded in 2023.
  • The largest YoY upside for Gains from Investment Securities was 6741.2% in 2025 against a maximum downside of 12252.48% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$5.5 million in 2021, then surged by 168.63% to $3.8 million in 2022, then tumbled by 108.21% to -$311000.0 in 2023, then surged by 132.48% to $101000.0 in 2024, then crashed by 12252.48% to -$12.3 million in 2025.
  • Per Business Quant, the three most recent readings for PIIIW's Gains from Investment Securities are -$12.3 million (Q4 2025), $2.5 million (Q3 2025), and -$2.0 million (Q2 2025).